Analysts Predict 18% Growth Potential for SMLF Holdings
ETF Analysis: The iShares U.S. Small-Cap Equity Factor ETF (SMLF) has an implied analyst target price of $87.79, indicating a potential upside of 17.66% from its current trading price of $74.61.
Notable Holdings: Key underlying holdings with significant upside potential include Amplitude Inc (40.90% upside), RADCOM Ltd. (35.14% upside), and Cimpress PLC (28.22% upside) based on their respective analyst target prices.
Market Sentiment: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to downgrades if they do not align with current market conditions.
Investor Research: It emphasizes the need for further investor research to assess the validity of analyst targets in light of recent company and industry developments.
Trade with 70% Backtested Accuracy
Analyst Views on AMPL
About AMPL
About the author

- Amplitude Revenue Growth: Amplitude reported Q1 revenues of $93.49 million, reflecting a year-over-year increase of 16.9% and exceeding analyst expectations by 0.6%, although the full-year EPS guidance fell short, indicating ongoing growth potential in the digital analytics platform sector.
- Palantir's Strong Performance: Palantir reported Q1 revenues of $1.63 billion, up 84.7% year-over-year, surpassing analyst expectations by 6.1%, and despite an 11.1% drop in stock price, its leadership in data integration and analysis remains solid.
- Domo's Weak Performance: Domo reported Q1 revenues of $79.4 million, flat year-over-year, missing analyst expectations by 0.6%, and while its stock rose 18.2%, its underperformance raises concerns about future growth in a competitive landscape.
- Samsara's Strong Growth: Samsara reported Q1 revenues of $478.8 million, a 30.5% year-over-year increase, exceeding analyst expectations by 5.2%, and its future EPS guidance also surpassed expectations, indicating robust demand in the IoT platform sector.
- Coverage Initiation: Raymond James has initiated coverage on AI analytics firm Amplitude (AMPL) with a Strong Buy rating and a $10 price target, reflecting confidence in its future growth potential.
- Growth Acceleration Outlook: Analysts noted that Amplitude is entering a multi-year growth acceleration phase, expected to achieve strong incremental margin expansion that should drive valuation multiple expansion, indicating optimistic market expectations for its performance.
- Revenue Forecast: Amplitude forecasts FY2026 revenue between $397 million and $403 million, indicating the addition of $16 million in incremental ARR from its partnership with Statsig, further enhancing its financial outlook.
- Market Confidence Boost: With the analysts' positive rating and upward revenue expectations, market confidence in Amplitude has significantly increased, potentially attracting more investor attention and driving stock price appreciation.
- Abbott Labs Upgrade: Baird initiates coverage on Abbott Labs (ABT) with an outperform rating, projecting steady revenue and earnings growth of 6-8% over the next few years, bolstered by its leading position in the rapidly growing MedDevice market, enhancing the company's competitive edge.
- Murphy USA Upgrade: Jefferies upgrades Murphy USA (MUSA) from hold to buy, citing improving fuel margins that are expected to drive EBITDA outlook significantly higher by 20-25%, which will materially enhance the company's financial performance in the coming years.
- Abivax Upgrade: Jefferies raises Abivax (ABVX) to buy, noting strong data for its ulcerative colitis drug that alleviates key market concerns, which is likely to drive a rebound in the stock price.
- Talos Energy Upgrade: Roth upgrades Talos Energy (TALO) from neutral to buy, raising the price target by 6% to $17, based on its robust balance sheet and low production decline rates, indicating strong future growth potential.
- Executive Stock Sale: Amplitude's CTO Curtis Liu sold 22,201 shares on June 1, 2026, for approximately $178,000, indicating a non-discretionary decision amid current market pressures.
- Holding Percentage Change: This transaction represented 2.16% of Liu's direct holdings, leaving him with 1,004,779 shares, reflecting a 9.3% reduction since March 2026, suggesting a cautious outlook on the company's future.
- Transaction Plan Context: The stock sale was executed under a 10b5-1 trading plan adopted on November 26, 2025, indicating it was non-discretionary and aimed at avoiding insider trading allegations, thereby enhancing market transparency.
- Market Performance Analysis: Despite Liu's stock sale, Amplitude reported $93.5 million in sales for Q1 2026, a 17% year-over-year increase, with projected revenue for 2026 expected to reach between $397 million and $403 million, demonstrating resilience in its analytics business amid AI competition.
- Guidance Reduction: On May 6, 2026, Amplitude announced a significant reduction in its fiscal year 2026 non-GAAP operating income guidance to a range of $2.5 million to $6.5 million, down from previous expectations of $7 million to $13 million, indicating increased pressure on profitability.
- Stock Price Reaction: Following the guidance revision, Amplitude's stock price fell by $1.61, or 21.41%, closing at $5.91 per share on May 7, 2026, reflecting investor concerns regarding the company's future profitability.
- Analyst Downgrade: Bank of America downgraded Amplitude due to concerns about rising execution risks and a weaker profitability outlook linked to its partnership strategy and increasing AI-related costs, suggesting potential margin compression.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Amplitude and its officers have engaged in securities fraud or other unlawful business practices, advising investors to contact the firm for information on joining the class action.
- Guidance Revision: On May 6, 2026, Amplitude announced a reduction in its fiscal year 2026 non-GAAP operating income guidance to a range of $2.5 million to $6.5 million, down from previous expectations of $7 million to $13 million, indicating increased pressure on profitability that could undermine investor confidence.
- Analyst Downgrade: Bank of America downgraded Amplitude due to concerns over rising execution risks and a weaker profitability outlook linked to its partnership strategy and increasing AI-related costs, reflecting a market sentiment that may diminish investor trust in the company's future performance.
- Stock Price Decline: Following the announcement, Amplitude's stock price fell by $1.61, or 21.41%, closing at $5.91 per share on May 7, 2026, a significant drop that could trigger further investor scrutiny and impact the company's market reputation.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Amplitude and its executives have engaged in securities fraud or other unlawful business practices, which may exacerbate market unease and affect shareholder trust and investment decisions.









